Signant’s innovative clinical trial technologies help researchers improve the quality of life for people living with HIV (PLWHIV) by advancing antiretroviral therapies (ART).

We help Human Immunodeficiency Virus (HIV) studies:

• Achieve optimal adherence
• Reduce burdens for sites & study teams
• Maximize IP supply chain efficiency
• Collect objective measures on activity & sleep
• Enable accurate ClinROs

Take a look at our HIV brochure for more details on how we can help studies like yours.